Taurine 7 pp 341-349 | Cite as

The Effects of Dietary Taurine Supplementation on Bone Mineral Density in Ovariectomized Rats

  • Mi-Ja Choi
  • Nancy M. DiMarco
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 643)


This study was performed to evaluate the effect of a diet rich in taurine (2.0 g/100 g) on bone metabolism in ovariectomized (OVX) rats. All rats were fed deionized water during the experimental period. Bone mineral density (BMD) and bone mineral content (BMC) of spine and femur were measured. Serum and urinary calcium and phosphorus content were determined. The levels serum osteocalcin and alkaline phosphatase (ALP) were used to assess bone formation. The rate of bone resorption was measured by the deoxypyridinoline (DPD) crosslink immunoassay and corrected for creatinine. Urinary Ca and P excretion, serum osteocalcin content, and the crosslink value were not significantly different between the Sham groups. The taurine supplemented, Sham group had higher spinal and femur BMC than those of the untreated control group, but the difference was not statistically significant. However, the taurine supplemented, Sham group had significantly higher spine and femur BMC per weight than those of the untreated control group. Within the OVX group, the taurine supplemented group had a lower crosslink value than the casein group. The taurine supplemented, OVX group had higher femur bone mineral content per weight than those of the control, OVX group, but the difference was not statistically significant. A study examining the long-term effect of taurine supplementation in humans is warranted.


Bone Mineral Density Sham Group Bone Mineral Content Short Bowel Syndrome Serum Osteocalcin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Booth SL, Tucker KL, Chen H, Hannan MT, Gagnon DG, Cupples LA, Wilson PWF, Ordovas J, Schaefer EJ, Dawson-Hughes B, Kiel DP (2000) Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr 71:1201–1208PubMedGoogle Scholar
  2. Boujendar S, Reusens B, Merezak S, Ahn M T, Arany E, Hill D, Remacle C (2002) Taurine supplementation to a low protein diet during foetal and early postnatal life restores a normal proliferation and apoptosis of rat pancreatic islets. Diabetologia 45:856–866PubMedCrossRefGoogle Scholar
  3. Chrischilles EA, Butler CD, Davis CS, Wallace RB (1990) A model of lifetime steoporosis impact. Arch Intern Med 151:2026–2032CrossRefGoogle Scholar
  4. Dolan P, Torgerson DJ (1998) The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int 8:611–617PubMedCrossRefGoogle Scholar
  5. Ebeling PR, Jones JD, O’Fallon WM, Janes CH, Riggs BL. (1993) Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. J Clin Endocrinol Metab 77:1384–1387PubMedCrossRefGoogle Scholar
  6. Edwards CJ, Hart DJ, Spector TD (2000) Oral ststins and increased bone-mineral density in postmenopausal women. Lancet 355; 2218–2219PubMedCrossRefGoogle Scholar
  7. Furukawa S, Katto M, Kouyama H, Nishida I, Kikumori M, Taniguchi Y, Toda T., Araki H (1991) Repeated dose toxicity study of intravenous treatment with taurine for 13 weeks and recovery test for 5 weeks in rats. Jap Phar Thera 19:275–306Google Scholar
  8. Ghiron L, Thompson JL, Holloway L (1995) Effects of recombinant insulin-like growth factor-1 and growth hormone on bone turnover in elderly women. J BoneMiner Res 10:1844–1852CrossRefGoogle Scholar
  9. Grinspoon SK, Baum HBA, Peterson S, Klibanski A. (1995) Effects of rhIGF-I administration on bone turnover during short-term fasting. J Clin Invest 96:900–906PubMedCrossRefGoogle Scholar
  10. Heaney RP (1993) Nutritional factors in osteoporosis. Annu Rev Nutr 13:287–316PubMedCrossRefGoogle Scholar
  11. Huxtable RJ (1992) Physiological actions of taurine. Physiol. Rev 72:101–163PubMedGoogle Scholar
  12. Ilich JZ, Kerstetter JE (2000) Nutrition in bone health revisited: a story beyond calcium. J Am Coll Nutr 19:715–737PubMedGoogle Scholar
  13. Jalava T, Sarna S, Pylkkanen L, Mawer B, Kamichael-Davies JA, Adams J, Francis RM, Robinson J, Euge (2003) Association between vertebral fracture and increased mortality in osteoporotic patients. J Bone Miner Res 18:1254–1260PubMedCrossRefGoogle Scholar
  14. Jensen C, Holloway L, Block G, Spiller G, Gildengorin G, Gunderson E, Butterfield G, Marcus R (2002) Long-term effects of nutrient intervention on markers of bone remodeling and calciotropic hormones in late-postmenopausal women. Am J Clin Nutr 75:1114–1120PubMedGoogle Scholar
  15. Jeri WN (2005) Supplement: women and micronutrients:Addressing the gap throughout the life cycle: Osteoporosis: the role of micronutrients. Am. J. Clinical Nutrition 81:1232S–1239SGoogle Scholar
  16. Melton LJ III (2003) Adverse outcomes of osteoporotic fractures in the general population. J Bone Miner Res 18:1139–1141PubMedCrossRefGoogle Scholar
  17. Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN (1996) Risk factors for osteoporoticfractures in elderly men. Am J Epidemiol 144:255–263PubMedGoogle Scholar
  18. Raisz LJ (1999) Osteoporosis: current approaches and future prospects in diagnosis, pathogenesis and management. J Bone Miner Res 17:79–89CrossRefGoogle Scholar
  19. Reeves PG, Nielsen FH, Fahey GC (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the Reformulation of the AIN 76 A Rodent Diet. J Nutr 123:1939–1951PubMedGoogle Scholar
  20. Sjogren K, Liu JL, Blad K (1999) Liver-derived insulin-like growth factor I (IGH-I) is the principal source of IGF-Iin blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 96:7088–7092PubMedCrossRefGoogle Scholar
  21. Stafford RS, Brieling RL, Hersh AL (2004) National trends in osteoporosis visits and osteoporosis treatment . Arch Intern Med 164:1525–1530PubMedCrossRefGoogle Scholar
  22. Sturman, G. A (1993) Taurine in development. Physiol. Rev 73:119–147PubMedGoogle Scholar
  23. Tangpricha M, Luo C, Fernandez-Estivariz LH, Gu N, Bazargan JM, Klapproth SV, Sitaraman JR, Galloway LM, Leader T R, Ziegler (2006) Growth hormone favorably affects bone turnover and bone mineral density in patients with short bowel syndrome undergoing intestinal rehabilitation. JPEN 30:480–486Google Scholar
  24. Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PWF, Kiel DP (1999) Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr 69:727–736PubMedGoogle Scholar
  25. Yakar S, Rosen CJ, Beamer WG (2002) Circulating levels of IGF-1 directly regulatebone growth and density. J ClinInvest 110:771–781Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Mi-Ja Choi
    • 1
  • Nancy M. DiMarco
  1. 1.Department of Food and NutritionKeimyung UniversityDaeguKorea

Personalised recommendations